Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis

Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis

No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). This network meta-analysis assessed the comparative efficacy and acceptability of licensed dose aqueous INCSs. PubMed/MEDLINE, Scopus, EMBASE, and the Cochrane C...

Full description

Bibliographic Details
Main Authors: Kay Khine Soe, Thanachit Krikeerati, Chatkamol Pheerapanyawaranun, Suvimol Niyomnaitham, Phichayut Phinyo, Torpong Thongngarm
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pharmacology
Subjects:
acceptability
allergic rhinitis
efficacy
intranasal corticosteroid
meta-analysis
systematic review
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1184552/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1184552/full

Similar Items